FDA recall D-0446-2021

Cardinal Health Inc. · Class II · drug

Product

TOBRAMY/DEX 0.3-0.1% 10ML OPTH; NDC/UPC 24208029510; RX; DROPS

Reason for recall

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Distribution

FL, GA, SC

Key facts

Status
Terminated
Initiation date
2021-03-15
Report date
2021-06-02
Termination date
2024-06-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Dublin, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0446-2021